Sagent has launched Irinotecan Injection, the generic form of the chemotherapy drug Camptosar, in two latex-free, preservative-free single dose vials. The product is available in 40mg/2mL and 100mg/5mL single-dose vials.
Irinotecan HCl injection is an antineoplastic agent of the topoisomerase I inhibitor class. It is indicated in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
For more information call (866) 625-1618 or visit www.sagentpharma.com.